Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
…did not correlate with survival outcomes (p=0.6299).Conclusions TOX expression varied significantly among the studied groups, with …
… and thymus proteins that can serve as standardization factors. Thymomodulin stimulated cytokine production (TNF α and IL-1β) in THP-1 deriv…
…ed with established anti-CD3 T cell engagers. Here we show that TriSTAR0701, a hN4-targeting TCE, drives potent anti-tumor activity in huma…
…preclinical and translational development. The lead biparatopic CT224 (CDH17×CD3) TCE candidates exhibited potent tumor cell killing …
…ory T cells, and decreased tumor cell proliferation. Similarly, DPCEGFR exhibited anti-tumor efficacy comparable to anti-EGFR, correlat…
…D) SCS intake duration was 23.5 (21.3) and 34.9 (26.4) days for dupilumab and placebo, respectively; antibiotic intake duration was 17.8 …
…ase and impact on patients’ lives. Nalbuphine extended-release (NAL ER, oral tablet form) is a kappa receptor agonist and mu receptor …
…Background Pirfenidone and Nintedanib are antifibrotic medications licensed in the UK for Idopathetic…
…nce and reliever therapy, were suggested. Patients liked use of FeNO to monitor changes in inflammation and assess the impact of man…
… (39.4%), deranged liver function (9.2%) and weight loss (5.7%).Nintedanib was discontinued in 27 patients and was due to diarrhoea 38.4%,…
…thelial and endothelial barrier, resulting in pulmonary oedema. Baricitinib is a JAK1/2 inhibitor which inhibits inflammation in experiment…